Dr. Adi Mor
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dr. Adi Mor
Dr. Adi Mor is recorded as CEO at Chemomab Therapeutics Ltd. (CMMB). Chemomab Therapeutics Ltd. reported in an 8-K filed June 5, 2023 that Dr. Adi Mor was appointed Chief Executive Officer, effective June 1, 2023.
“On June 1, 2023, the board of directors (the “Board”) of Chemomab Therapeutics Ltd. (the “Company” or “Chemomab”) appointed Dr. Adi Mor, co-founder of the Company, a current class III member of the Board and the Company’s Chief Scientific Officer, as Chief Executive Officer of the Company to replace Dr. Dale Pfost, effective as of the same date.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-06-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Chemomab Therapeutics Ltd.
Other people whose current roles at this company are on record from its filings.
- Adi Mor CEO, Board Member
- Dale Pfost CEO, Board Member
- Dr. Dale Pfost CEO
- Neil Cohen CEO, Board Member
- Dr. Nissim Darvish Chairman
- Stephen Squinto Chairman, Board Member
- Andrew Fine CFO
- Donald Marvin CFO, COO
- Ms. Sigal Fattal CFO
- Sigal Fattal CFO
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.